Lincoln Pharmaceuticals consolidated net profit rises 29.64% in the September 2016 quarter

Sales decline 18.53% to Rs 74.27 crore

Net profit of Lincoln Pharmaceuticals rose 29.64% to Rs 8.66 crore in the quarter ended September 2016 as against Rs 6.68 crore during the previous quarter ended September 2015. Sales declined 18.53% to Rs 74.27 crore in the quarter ended September 2016 as against Rs 91.16 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales74.2791.16 -19 OPM %19.5812.87 -PBDT12.779.86 30 PBT11.498.75 31 NP8.666.68 30

Powered by Capital Market - Live News